BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29744181)

  • 1. Repurposing AM404 for the treatment of oral infections by Porphyromonas gingivalis.
    Gerits E; Spincemaille P; De Cremer K; De Brucker K; Beullens S; Thevissen K; Cammue BPA; Vandamme K; Fauvart M; Verstraeten N; Michiels J
    Clin Exp Dent Res; 2017 Apr; 3(2):69-76. PubMed ID: 29744181
    [No Abstract]   [Full Text] [Related]  

  • 2. Repurposing Toremifene for Treatment of Oral Bacterial Infections.
    Gerits E; Defraine V; Vandamme K; De Cremer K; De Brucker K; Thevissen K; Cammue BP; Beullens S; Fauvart M; Verstraeten N; Michiels J
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica nanoparticles containing nano-silver and chlorhexidine to suppress
    Fang L; Zhang Y; Cheng L; Zheng H; Wang Y; Qin L; Cai Y; Cheng L; Zhou W; Liu F; Wang S
    J Oral Microbiol; 2024; 16(1):2361403. PubMed ID: 38847000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soybean peptide inhibits the biofilm of periodontopathic bacteria via bactericidal activity.
    Lwin HY; Aoki-Nonaka Y; Matsugishi A; Takahashi N; Hiyoshi T; Tabeta K
    Arch Oral Biol; 2022 Oct; 142():105497. PubMed ID: 35849907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-based oral care product exhibits antibacterial effects on different stages of oral multispecies biofilm development in vitro.
    Kommerein N; Weigel AJ; Stiesch M; Doll K
    BMC Oral Health; 2021 Apr; 21(1):170. PubMed ID: 33794846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attachment of Porphyromonas gingivalis to corroded commercially pure titanium and titanium-aluminum-vanadium alloy.
    Barão VA; Yoon CJ; Mathew MT; Yuan JC; Wu CD; Sukotjo C
    J Periodontol; 2014 Sep; 85(9):1275-82. PubMed ID: 24444400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms.
    Rocco CJ; Bakaletz LO; Goodman SD
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29437850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplanktonic and Antibiofilm Activity of
    Kommerein N; Vierengel N; Groß J; Opatz T; Al-Nawas B; Müller-Heupt LK
    Microorganisms; 2022 May; 10(5):. PubMed ID: 35630409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High in vitro antibacterial activity of Pac-525 against Porphyromonas gingivalis biofilms cultured on titanium.
    Li JY; Wang XJ; Wang LN; Ying XX; Ren X; Liu HY; Xu L; Ma GW
    Biomed Res Int; 2015; 2015():909870. PubMed ID: 25710035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and antibiofilm activities of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) against periodontopathic bacteria.
    Sun M; Zhou Z; Dong J; Zhang J; Xia Y; Shu R
    Microb Pathog; 2016 Oct; 99():196-203. PubMed ID: 27565090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of D-arginine on Porphyromonas gingivalis biofilm.
    Li YY; Li BS; Liu WW; Cai Q; Wang HY; Liu YQ; Liu YJ; Meng WY
    J Oral Sci; 2020; 62(1):57-61. PubMed ID: 31996524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antibiotic medicaments against biofilm formation of Enterococcus faecalis and Porphyromonas gingivalis.
    Sabrah AH; Yassen GH; Gregory RL
    J Endod; 2013 Nov; 39(11):1385-9. PubMed ID: 24139259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response.
    Zhou W; Zhang X; Zhu CL; He ZY; Liang JP; Song ZC
    PLoS One; 2016; 11(11):e0166442. PubMed ID: 27832188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the tea catechin epigallocatechin gallate on Porphyromonas gingivalis biofilms.
    Asahi Y; Noiri Y; Miura J; Maezono H; Yamaguchi M; Yamamoto R; Azakami H; Hayashi M; Ebisu S
    J Appl Microbiol; 2014 May; 116(5):1164-71. PubMed ID: 24471579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Japanese traditional herbal medicines (Kampo) on growth and virulence properties of Porphyromonas gingivalis and viability of oral epithelial cells.
    Liao J; Zhao L; Yoshioka M; Hinode D; Grenier D
    Pharm Biol; 2013 Dec; 51(12):1538-44. PubMed ID: 23987742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antibacterial and cytotoxic activities of carvacrol and terpinen-4-ol against biofilm formation on titanium implant surfaces.
    Maquera-Huacho PM; Tonon CC; Correia MF; Francisconi RS; Bordini EAF; Marcantonio É; Spolidorio DMP
    Biofouling; 2018 Jul; 34(6):699-709. PubMed ID: 30187780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial and antibiofilm activities of novel antimicrobial peptide DP7 against the periodontal pathogen Porphyromonas gingivalis.
    Jiang SJ; Xiao X; Zheng J; Lai S; Yang L; Li J; Liu C; Yang Y; Mu Y
    J Appl Microbiol; 2022 Aug; 133(2):1052-1062. PubMed ID: 35567537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of plant species used for oral health against Porphyromonas gingivalis.
    Carrol DH; Chassagne F; Dettweiler M; Quave CL
    PLoS One; 2020; 15(10):e0239316. PubMed ID: 33031410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of D-arginine, D-methionine and D-histidine against
    Zhang Z; Li B; Cai Q; Qiao S; Wang D; Wang H; Zhang H; Yang Y; Meng W
    Biofouling; 2021 Feb; 37(2):222-234. PubMed ID: 33682548
    [No Abstract]   [Full Text] [Related]  

  • 20. A peptide coating preventing the attachment of Porphyromonas gingivalis on the surfaces of dental implants.
    Fang D; Yuran S; Reches M; Catunda R; Levin L; Febbraio M
    J Periodontal Res; 2020 Aug; 55(4):503-510. PubMed ID: 32096230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.